nevirapine has been researched along with adam ii in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckheit, RW; Burrier, J; Cushman, M; Hartman, TL; Micklatcher, M; Osterling, MC; Silvestri, MA; Turpin, JA; Wargo, H; Xu, G | 1 |
Buckheit, RW; Clercq, ED; Cullen, MD; Cushman, M; Deng, BL; Hartman, TL; Pannecouque, C; Watson, KM | 1 |
Buckheit, RW; Cullen, MD; Cushman, M; De Clercq, E; Hamel, E; Hartman, TL; Pannecouque, C; Sarkar, T; Watson, KM | 1 |
3 other study(ies) available for nevirapine and adam ii
Article | Year |
---|---|
The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors.
Topics: Alkenes; Benzene Derivatives; Cell Line; Cytopathogenic Effect, Viral; Drug Resistance, Multiple; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Models, Molecular; Monocytes; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 2001 |
Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability.
Topics: Alkenes; Animals; Anti-HIV Agents; Benzoates; Cytopathogenic Effect, Viral; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Hydrolysis; Mutation; Nitriles; Oxadiazoles; Oxazoles; Rats; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Tetrazoles | 2007 |
Inhibition of tubulin polymerization by select alkenyldiarylmethanes.
Topics: Biopolymers; Cell Line, Tumor; Drug Screening Assays, Antitumor; HIV Reverse Transcriptase; Humans; Methane; Reverse Transcriptase Inhibitors; Tubulin | 2008 |